Hypogammaglobulinemia in pediatric liver transplant recipients

Pediatric Transplantation

Volumn 9, Issue 2, 2005, Pages 215-219

  Ganschow, Rainer ^a   Englert, C ^a   Grabhorn, E ^a   Richter, A ^a   Hinrichs, B ^a   Broering, D C ^a   Rogiers, X ^a   Burdelski, M ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Children; Hypogammaglobulinemia; Liver transplantation

Indexed keywords

BASILIXIMAB; CYCLOSPORIN A; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; STEROID;

ACUTE GRAFT REJECTION; ARTICLE; ASCITES; BILE DUCT ATRESIA; CASE REPORT; HUMAN; HYPOGAMMAGLOBULINEMIA; IMMUNOSUPPRESSIVE TREATMENT; INFANT; LIVER FAILURE; LIVER GRAFT; LIVER TRANSPLANTATION; MALE; NEPHROTOXICITY;

AGAMMAGLOBULINEMIA; BILIARY ATRESIA; CHILD; COMMON VARIABLE IMMUNODEFICIENCY; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULINS, INTRAVENOUS; INFANT; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; LYMPHOCYTE SUBSETS;

EID: 16444371892     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2005.00291.x     Document Type: Article

References (13)

1. CORALES R, CHUA J, MAWHORTER SD, et al. Significant posttransplant hypogammaglobulinemia in six heart transplant recipients: an emerging clinical phenomenon? Transpl Infect Dis 2000: 2: 133-139.
2. SMOLIN MR, RICKMAN W, HASBARGEN J. Hypogammaglobulinemia in a renal transplant recipient with antiglomerular basement membrane disease. Am J Kidney Dis 1988: 11: 267-269.
3. POLLOCK CA, MAHONY JF, IBELS LS, et al. Immunoglobulin abnormalities in renal transplant recipients. Transplantation 1989: 47: 952-956.
4. LEE WA, MIKSZTAL AR, CHU N, LEUNG K, NELSON PH. Bioavailability improvement of mycophenolic acid through amino ester derivatization. Pharm Res 1990: 7: 161-165.
5. GOLDFARB NS, AVERY RK, GOORMASTIC M, et al. Hypogammaglobulinemia in lung transplant recipients. Transplantation 2001: 71: 242-246.
6. GANSCHOW R, LYONS M, KEMPER MJ, BURDELSKI M. B-cell dysfunction and depletion using mycophenolate mofetil in a pediatric combined liver and kidney graft recipient. Pediatr Transpl 2001: 5: 60-63.
7. VERSCHUUREN EA, STEVENS SJ, VAN IMHOFF GW, et al. Treatment of posttransplant lymphoproliferative disease with rituximab: the remission, the relapse and the complications. Transplantation 2002: 73: 100-104.
8. YAMANI MH, AVERY RK, MAWHORTER SD, et al. Hypogammaglobulinemia following cardiac transplantation: a link between rejection and infection. J Heart Lung Transplant 2001: 20: 425-429.
9. Yu DT, CLEMENTS PJ, PAULUS HE, et al. Human lymphocyte subpopulations. Effects of corticosteroids. J Clin Invest 1974: 53: 565-571.
10. HAMMARSTROM L, VORECHOVSKY I, WEBSTER D. Selective IgA deficiency (sIgAD) and common variable immunodeficiency (CVID). Clin Exp Immunol 2000: 120: 225-231.
11. DE LA CONCHA EG, FERNANDEZ-ARQUERO M, MARTINEZ A, et al. HLA class II homozygosity confers susceptibility to common variable immunodeficiency (CVID). Clin Exp Immunol 1999: 116: 516-520.
12. DURAND P, DEBRAY D, MANDEL R, et al. Acute liver failure in infancy: a 14-year experience of a pediatric liver transplantation center. J Paediatr Child Health 2001: 139: 871-876.
13. GANSCHOW R, BROERING DC, STUERENBURG I, et al. First experience with basiliximab in pediatric liver graft recipients. Pediatr Transplant 2001: 5: 353-358.